These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9861886)

  • 41. Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection.
    Csajka C; Marzolini C; Fattinger K; Décosterd LA; Fellay J; Telenti A; Biollaz J; Buclin T
    Clin Pharmacol Ther; 2003 Jan; 73(1):20-30. PubMed ID: 12545140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. What's new and what's next.
    Fakuda D
    Posit Dir News; 1998 Jan; 10(1):25-9. PubMed ID: 11365053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Switching drugs for lipodystophy.
    Fornataro K
    Body Posit; 1999 May; 12(5):13. PubMed ID: 11366306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sustiva granted full FDA approval.
    AIDS Read; 2000 Mar; 10(3):147. PubMed ID: 10798886
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacokinetic interaction of amprenavir in combination with efavirenz or delavirdine in HIV-infected children.
    Wintergerst U; Engelhorn C; Kurowski M; Hoffmann F; Notheis G; Belohradsky BH
    AIDS; 2000 Aug; 14(12):1866-8. PubMed ID: 10985332
    [No Abstract]   [Full Text] [Related]  

  • 46. Efavirenz reclassified as FDA pregnancy category D.
    Mofenson LM
    AIDS Clin Care; 2005 Feb; 17(2):17. PubMed ID: 15754452
    [No Abstract]   [Full Text] [Related]  

  • 47. A once-daily combination tablet (Atripla) for HIV.
    Med Lett Drugs Ther; 2006 Sep; 48(1244):78-9. PubMed ID: 17001298
    [No Abstract]   [Full Text] [Related]  

  • 48. Paediatric treatment issues.
    Walters S
    Int J Clin Pract Suppl; 1999 Jun; 103():26-9. PubMed ID: 10622040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New expanded access drugs for use in combination therapy.
    Notes Undergr; 1998; (No 37):suppl 1-2. PubMed ID: 11365823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FDA approves Sustiva (efavirenz) capsules, first once-daily anti-HIV drug. Food and Drug Administration.
    Res Initiat Treat Action; 1998 Oct; 4(6):13-4. PubMed ID: 11365915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efavirenz (Sustiva).
    Res Initiat Treat Action; 2000 Mar; 6(1):22-3. PubMed ID: 11708181
    [No Abstract]   [Full Text] [Related]  

  • 52. Raising levels of amprenavi.
    AIDS Patient Care STDS; 2000 Nov; 14(11):618. PubMed ID: 11155905
    [No Abstract]   [Full Text] [Related]  

  • 53. Efavirenz + emtricitabine + tenofovir: new combination. HIV infection: do not modify ongoing therapy just to use one less tablet. Better adherence than with separate dosing has not been demonstrated, while reduced efficacy is plausible.
    Prescrire Int; 2009 Jun; 18(101):105. PubMed ID: 19637416
    [No Abstract]   [Full Text] [Related]  

  • 54. DMP 266 study opens at Jefferson.
    Crit Path AIDS Proj; 1997; (No 32):30-1. PubMed ID: 11364440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Once-daily highly active antiretroviral therapy for HIV-infected children: safety and efficacy of an efavirenz-containing regimen.
    Scherpbier HJ; Bekker V; Pajkrt D; Jurriaans S; Lange JM; Kuijpers TW
    Pediatrics; 2007 Mar; 119(3):e705-15. PubMed ID: 17308244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Non-nucleoside reverse transcriptase inhibitors. First line therapy].
    MMW Fortschr Med; 2000; 142(3 Suppl):34-5. PubMed ID: 10893964
    [No Abstract]   [Full Text] [Related]  

  • 57. NIAID comments on AACTG Study A5095.
    IAPAC Mon; 2003 Jun; 9(6):121. PubMed ID: 12951940
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment resistance after sequential interruption of a non-nucleoside reverse transcriptase inhibitor-based regimen.
    Dargere S; Parienti JJ; Verdon R
    AIDS; 2007 Apr; 21(7):879-80. PubMed ID: 17415047
    [No Abstract]   [Full Text] [Related]  

  • 59. How to start antiretroviral therapy?
    Horster S; Goebel FD
    Infection; 2004 Jun; 32(3):184-5. PubMed ID: 15188082
    [No Abstract]   [Full Text] [Related]  

  • 60. A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease.
    Fischl MA; Ribaudo HJ; Collier AC; Erice A; Giuliano M; Dehlinger M; Eron JJ; Saag MS; Hammer SM; Vella S; Morse GD; Feinberg JE; Demeter LM; Eshleman SH;
    J Infect Dis; 2003 Sep; 188(5):625-34. PubMed ID: 12934177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.